Financial Review: TMSR (TMSR) versus Global Cord Blood (CO)
TMSR (NASDAQ:TMSR) and Global Cord Blood (NYSE:CO) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, risk and institutional ownership.
This table compares TMSR and Global Cord Blood’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Global Cord Blood||25.36%||7.79%||4.15%|
0.0% of TMSR shares are held by institutional investors. Comparatively, 18.9% of Global Cord Blood shares are held by institutional investors. 47.0% of TMSR shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Global Cord Blood pays an annual dividend of $0.08 per share and has a dividend yield of 1.3%. TMSR does not pay a dividend.
Volatility and Risk
TMSR has a beta of 0.34, meaning that its share price is 66% less volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of 0.38, meaning that its share price is 62% less volatile than the S&P 500.
This is a breakdown of current recommendations and price targets for TMSR and Global Cord Blood, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Global Cord Blood||0||0||0||0||N/A|
Valuation and Earnings
This table compares TMSR and Global Cord Blood’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Global Cord Blood||$149.34 million||5.13||$37.79 million||N/A||N/A|
Global Cord Blood has higher revenue and earnings than TMSR.
Global Cord Blood beats TMSR on 8 of the 9 factors compared between the two stocks.
TMSR Company Profile
TMSR Holding Company Limited, together with its subsidiaries, focuses on the research, development, production, and sale of solid waste recycling systems for the mining and industrial sectors in the People's Republic of China. It is also involved in the iron ore trading, wine import and resale, and Agarwood wine trading businesses; and provision of ship exchange consulting services. The company was incorporated in 2015 and is based in Wuhan, China.
Global Cord Blood Company Profile
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2018, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).
Receive News & Ratings for TMSR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TMSR and related companies with MarketBeat.com's FREE daily email newsletter.